Our website is made possible by displaying online advertisements to our visitors.
Please consider supporting us by disabling your ad blocker.

PHARMA

Quarterly rpt on consolidated results for the financial period ended 30/6/2006

PHARMANIAGA BERHAD

Quarterly report for the financial period ended

30/06/2006
Quarter2
Financial Year End31/12/2006
The figureshave not been audited

SUMMARY OF KEY FINANCIAL INFORMATION
30/06/2006


INDIVIDUAL PERIOD
CUMULATIVE PERIOD
CURRENT YEAR QUARTER
PRECEDING YEAR CORRESPONDING QUARTER
CURRENT YEAR TO DATE
PRECEDING YEAR CORRESPONDING PERIOD
30/06/2006 
30/06/2005 
30/06/2006 
30/06/2005 
 
 
 
 
RM'000
RM'000
RM'000
RM'000
1Revenue
251,133
242,784
501,887
470,656
2Profit/(loss) before tax
8,266
14,312
17,177
32,561
3Profit/(loss) for the period
6,084
9,074
12,000
21,091
4Profit/(loss) attributable to ordinary equity holders of the parent
5,663
8,711
11,122
19,410
5Basic earnings/(loss) per share (sen)
5.29
8.51
10.40
19.00
6Proposed/Declared dividend per share (sen)
11.50
10.50
11.50
10.50



AS AT END OF CURRENT QUARTER
AS AT PRECEDING FINANCIAL YEAR
END
7
Net assets per share attributable to ordinary equity holders of the parent (RM)

2.9600
2.9700

Note: For full text of the above announcement, please access KLSE Web site at www.klse.com.my


Remarks :
No interim ordinary dividend has been declared for the financial period ended 30 June 2006 (2005:nil).


Announcement Info

Company NamePHARMANIAGA BERHAD  
Stock Name PHARMA    
Date Announced16 Aug 2006  
CategoryFinancial Results
Reference NoPB-060801-61915